Drugs / Tenoten
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03036293 | Feb 2017 → Sep 2018 | anxiety | Materia Medica Holding | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tenoten | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03036293 ↗ |
| Route | Oral | “Tablet for oral use.” NCT03036293 ↗ |